Alvaro Yepes Villate Alsico Iberia Group
Alvaro Yepes Villate Alsico Iberia Group Technical Director, Contamination Control
Technical Sales Director - Expert in Materials for Critical Pharmaceutical Areas - |CCS Contamination Prevention & Control As Technical Sales Director in selection of materials for pharmaceutical production zones and proper use techniques, I combine technical expertise with strategic insight to ensure product integrity through the proper SOP and training of operators with the right materials for critical environments (cleanrooms, sterile areas, containment zones). I lead a consultative sales process focused on contamination risk prevention—particulate, fiber, microbiological, or cross-contamination—helping production, quality, and validation teams identify vulnerabilities in their current processes. I help industry professionals when they are seeking proactive approach to fewer product rejections due to contamination or non-conformities, reduced risk of product loss, batch failure, downtime, or costly reprocessing, enhanced compliance with GMP, Annex 1, and global regulatory standards. Protection of company reputation in audits and prevention of recalls my goal is to help pharmaceutical manufacturers ensure maximum product safety with minimal risk and optimal cost efficiency. I collaborate directly with technical departments to align material solutions with real production processes, considering room classifications, material flows, risk matrices, and regulatory targets. My focus is not just on supplying a product, but on applying specialized knowledge and experience to each client’s unique operational context.
Added value: Technical assessment of material performance and process compatibility Support in validation, testing, and documentation for audit readiness Technical training on proper use and handling of materials in GMP environments A constant focus on ensuring drug safety while optimizing process efficiency Let’s connect to explore how science-driven material choices can improve both regulatory robustness and operational outcomes.